 Tuesday, March 23rd 11am Eastern Time RALEIGH, NC ACCESSWIRE March 15, 2021 9 Meters Biopharma NASDAQ:NMTR, a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that it will host a key opinion leader KOL webinar on short bowel syndrome SBS and provide an update on the NM-002 proprietary GLP-1 agonist development program on Tuesday, March 23, 2021 at 11am Eastern Time. The webinar will feature presentations by KOLs Carol Rees Parrish, M.S. 